Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With

Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With ABC-DLBCL

Although ibrutinib adds to the cost of treatment, its benefits over the long term justify the cost, investigators found.

Related Keywords

Phoenix , Arizona , United States , , Image Credit , Ibrutinib , R Chop , Abc Dlbcl , Btk Inhibitor , I Rchop ,

© 2025 Vimarsana